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Summary
Glucocorticoids play an important role in adipogenesis through the glucocorticoid receptor (GR) that forms a heterocomplex with
Hsp90NHsp70 and one high molecular weight immunophilin, either FKBP51 or FKBP52. When 3T3-L1 preadipocytes are induced to
differentiate, FKBP51 expression progressively increases, whereas FKBP52 decreases, and Hsp90, Hsp70, p23 and Cyp40 remain
unchanged. Interestingly, FKBP51 rapidly translocates from mitochondria to the nucleus where it is retained upon its interaction with
chromatin and the nuclear matrix. FKBP51 nuclear localization is transient, and after 48 hours it cycles back to mitochondria.
Importantly, this dynamic FKBP51 mitochondrial–nuclear shuttling depends on PKA signaling, because its inhibition by PKI or
knockdown of PKA-ca by siRNA, prevented FKBP51 nuclear translocation induced by IBMX. In addition, the electrophoretic pattern of
migration of FKBP51 is altered by treatment of cells with PKI or knockdown of PKA-ca, suggesting that FKBP51 is a PKA substrate. In
preadipocytes, FKBP51 colocalizes with PKA-ca in mitochondria. When adipogenesis is triggered, PKA-ca also moves to the nucleus
colocalizing with FKBP51 mainly in the nuclear lamina. Moreover, FKBP51 and GR interaction increases when preadipocytes are
induced to differentiate. GR transcriptional capacity is reduced when cells are incubated in the presence of IBMX, forskolin or dibutyryl-
cAMP, compounds that induced FKBP51 nuclear translocation, but not by a specific activator of EPAC. FKBP51 knockdown facilitates
adipogenesis, whereas ectopic expression of FKBP51 blocks adipogenesis. These findings indicate that the dynamic mitochondrial–
nuclear shuttling of FKBP51 regulated by PKA may be key in fine-tuning the transcriptional control of GR target genes required for the
acquisition of adipocyte phenotype.
Key words: FKBP51, Glucocorticoid receptor, PKA, Adipogenesis
Introduction
For a long time, the sole physiological roles attributed to adipose
tissue were storage of energy and thermal regulation. However,
during the last two decades, it has been demonstrated that this
tissue is a complex endocrine organ, secreting many factors,
including cytokines, chemokines and the commonly called
adipokines, which are biologically active molecules that
participate in the control not only of energy balance, but also
metabolic homeostasis, the immune response and the
cardiovascular system (Klaus, 2004; Rajala and Scherer, 2003;
Steinberg, 2007). The importance of the endocrine functions of
adipose tissue is demonstrated in overweight and obesity
conditions that are associated with increased adipocyte size, as
well as increased development of new adipocytes (Flegal et al.,
2012). Obesity is a serious health problem world-wide because of
the increased prevalence of associated diseases such as type 2
diabetes, atherosclerosis, hypertension coronary artery disease,
and even increase in predisposition to certain cancers that are
associated with deregulated adipokine expression (Steinberg,
2007; van Kruijsdijk et al., 2009).
Obesity is not a homogeneous condition and differences in
regional distribution of adipose tissue deposits are related to
disturbances in glucose and lipid metabolism (Wajchenberg,
2000). In this respect, glucocorticoids are key regulators not only
of fat redistribution, but also of adipocyte differentiation as
demonstrated both in vitro and in vivo (Gaillard et al., 1991;
Gregoire et al., 1998). Glucocorticoids are present in the
‘adipogenic cocktail’ that induces the differentiation of 3T3-L1
or 3T3-F442a preadipocytes (Green and Kehinde, 1975). Their
adipogenic effect is evident in the development of central obesity
in patients with high levels of circulating glucocorticoids, as
observed in Cushing’s syndrome or in patients that required
prolonged administration of this steroid hormone therapeutically
(Newell-Price et al., 2006). Furthermore, adipose tissue-dependent
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amplification of corticosterone production in transgenic mice
results in a full metabolic syndrome, including central obesity,
insulin resistance and hypertension (Masuzaki et al., 2001). In
contrast, glucocorticoid inactivation is associated with resistance
to metabolic dysfunction (Kershaw et al., 2005; Morton et al.,
2004).
At the molecular level, glucocorticoid effects depend on the
hormone binding to glucocorticoid receptor (GR) that is present in
the cytoplasm as part of a heterocomplex with Hsp90, Hsp70, p23
and the high molecular weight immunophilins (IMMs), FKBP51 or
FKBP52 (Pratt and Toft, 1997). IMMs belong to a family of
proteins classified by their ability to bind immunosuppressant
drugs, for example cyclophilins bind cyclosporine A, whereas
FKBPs (FK506-binding proteins) bind FK506. The high molecular
weight IMMs FKBP51 and FKBP52 do not play a role in
immunosuppression, but have been related to steroid receptor
regulation (Storer et al., 2011). The FKBPs are modular proteins
that possess FKBP12-like peptidyl-prolyl isomerase (PPIase)
domains 1 and 2 and a tetratricopeptide repeat motif (TPR). The
FK1 domain is required for the binding of the immunosuppressive
drug FK506, it confers PPIase activity, and it is also the primary
domain required for steroid hormone receptor regulation (Pirkl and
Buchner, 2001; Riggs et al., 2003; Storer et al., 2011). The TPR
domain contains sequences of 34 amino acids repeated in tandem,
through which FKBPs interact with Hsp90. FKBP51 and FKBP52
share 60% identity and 70% similarity; however, the former has,
so far, been mainly reported to be a negative regulator of
steroid hormone receptors while the latter is a positive regulator
(Davies et al., 2002; Gallo et al., 2007; Riggs et al., 2003;
Storer et al., 2011; Wochnik et al., 2005). Furthermore, fkbp52-
deficient male mice display phenotypes related to partial
androgen insensitivity syndrome (Cheung-Flynn et al., 2005;
Yong et al., 2007). Heterozygous fkbp52-deficient mice show
increased susceptibility to high-fat-diet-induced hyperglycemia
and hyperinsulinemia that correlates with reduced insulin clearance,
hepatic steatosis and glucocorticoid resistance (Warrier et al.,
2010). In contrast, fkbp51-deficient mice were initially observed to
display no overt phenotypes, but these mice are less vulnerable to
the detrimental effects of stress (Hartmann et al., 2012; O’Leary
et al., 2011; Touma et al., 2011). However fkbp51-fkbp52 double
knockout results in embryonic lethality, demonstrating that these
IMMs have some physiological functional redundancies (Sivils
et al., 2011). Upon steroid hormone binding to GR, as well as to
mineralocorticoid receptor (MR) Hsp90 heterocomplexes, FKBP51
is released from the receptor complex and replaced by FKBP52,
which in turn recruits dynein–dynactin motor proteins favoring the
cytoplasmic transport of nuclear receptors (NRs) to the nucleus
(model in Fig. 8H) (Galigniana et al., 2010; Galigniana et al.,
2001). Interestingly, GR and its associated chaperones bind to
nuclear pore proteins such as nucleoporins and importin b, and it
has been shown that the entire Hsp90 heterocomplex cross-linked to
GR translocates intact through the nuclear pore in digitonin-
permeabilized cells (Echeverrı´a et al., 2009). Moreover, it has been
shown that the whole MRNHsp90-based heterocomplex can be
transiently recovered from the soluble fraction of the nucleus
shortly after steroid hormone incubation (Galigniana, 2012;
Galigniana et al., 2010; Grossmann et al., 2012). Thus, the
steroid-receptor transformation could possibly take place in the
nucleus.
Glucocorticoids regulate adipogenesis as well as the
distribution of adipose tissue; therefore, it is relevant to study
how they exert their action at the molecular level. When 3T3-L1
preadipocytes are induced to differentiate, GR is one of the NRs
expressed in a biphasic manner, with higher levels of mRNA
during the first days of adipogenesis, followed by a period
of lower level of mRNA that gradually increases back to
preadipocytes levels (Fu et al., 2005). In addition, genome-wide
studies have shown an increased cooperative binding of GR with
other adipogenic transcription factors during the early stages of
3T3-L1 preadipocyte differentiation (Siersbæk et al., 2011;
Steger et al., 2010). However, in spite of massive chromatin
remodeling and a high level of occupancy by transcription factors
in chromatin within hours of adipogenesis being induced, gene
expression is kept well controlled, and in many cases gene
expression takes place later in the adipogenic process (Siersbæk
et al., 2011). These findings emphasize the necessity for precise
control of GR action. However, nothing is known about proteins
in the heterocomplex that regulate GR activity during the process
of adipocyte differentiation. In this study we show for the first
time that when 3T3-L1 preadipocytes are induced to differentiate,
there are changes in the level of expression of the IMMs that
modulate GR responses. We found that the increase of FKBP51
protein level is accompanied by a decrease in FKBP52.
Surprisingly, FKBP51 shows dynamic changes in its
subcellular distribution throughout the process of adipogenesis.
Importantly, mitochondrial–nuclear shuttling of FKBP51
depends on the activation of protein kinase A (PKA) signaling
pathway, possibly constituting a mechanism for the fine tuning of
the expression of GR-target genes at the onset of the adipocyte
differentiation program.
Results
FKBP51 expression level increases during 3T3-L1
preadipocyte differentiation
Glucocorticoids are important mediators of adipocyte differentiation,
therefore, we first analyzed the pattern of expression of GR and the
components of GRNHsp90 heterocomplex at different time points
post-induction of murine 3T3-L1 preadipocyte differentiation. As
shown in Fig. 1A, GR protein expression was biphasic, its lowest
level occurring between the fourth to sixth day of 3T3-L1
differentiation, in agreement with a previous study in which GR
mRNA was analyzed in similar conditions (Fu et al., 2005). The
protein expression level of Hsp90, Hsp70, Cyp40 and p23 remained
constant (Fig. 1A). In contrast, FKBP51 and FKBP52 levels varied:
FKBP51 progressively increased, whereas FKBP52 gradually
decreased as the cells differentiated (Fig. 1A). Furthermore, an
increase in FKBP51 mRNA level was observed when 3T3-L1 cells
differentiated (Fig. 1B). No change in FKBP52 mRNA level was
detected (Fig. 1B), suggesting that changes in FKBP52 protein may
possibly depend on control of mRNA translation and/or protein
stability. The increased expression of C/EBPa and C/EBPb
(Fig. 1A), as well as the increased mRNA level of the adipogenic
markers adiponectin (Fig. 1B), C/EBPb and resistin (data not
shown) demonstrated that 3T3-L1 cells differentiated properly.
FKBP51 rapidly shuttles from mitochondria to the nucleus
at the onset of adipogenesis
Because the expression of FKBP51 increases throughout the
process of adipogenesis, we examined whether the subcellular
distribution of FKBP51 is modified when the differentiation
program of 3T3-L1 cells is triggered. In preadipocytes, FKBP51
was mainly detected in mitochondria (Fig. 2A), colocalizing with
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MitoTracker (Fig. 2D) and with Hsp70 (Fig. 2B, and merged
images in C), a chaperone also known to be present in
mitochondria. FKBP51 also colocalized with Tom20, one of
the import receptors required for the insertion of newly
synthesized proteins into the outer membrane of the
mitochondria (Bains and Lithgow, 1999) (supplementary
material Fig. S1A,B and merged image in C), further
demonstrating that in 3T3-L1 preadipocytes FKBP51 localizes
mainly in mitochondria. Interestingly, when adipogenesis was
induced FKBP51 translocated from mitochondria to the nucleus
(Fig. 1E), no longer colocalizing with MitoTracker (Fig. 1H) and
Tom20 (supplementary material Fig. S1F). Hsp70, albeit to a
lesser extent, was also detected in the nucleus (Fig. 2F) and
partially colocalized with FKBP51 (Fig. 2G). FKBP51 and
Hsp70 nuclear translocation was observed in 8465% of cells.
It was a rapid event as they were detected in the nucleus within
30 minutes of treating 3T3-L1 with MDI [3-isobutyl-1-
methylxanthine (IBMX), dexamethasone (DEXA) and insulin]
(data not shown). During the first 2 days post-induction of
adipogenesis, FKBP51 was detected in the nucleus but was
always excluded from the nucleoli (arrows in Fig. 2I;
supplementary material Fig. S1D), which were identified by the
presence of fibrillarin (Fig. 2J; no colocalization was observed
between these two proteins Fig. 2K). Analyzing in detail the
nuclear pattern of FKBP51, the IMM was detected diffusely
distributed and in speckles (Fig. 2I, arrowheads). The FKBP51
speckles coincided with areas intensely stained by DAPI (Fig. 2L
and merged K) that in murine cells correspond to the
chromocenters (Guenatri et al., 2004). From the third day of
Fig. 1. FKBP51 expression increases during the process of 3T3-L1
preadipocyte differentiation. (A) 3T3-L1 cells were differentiated for the
indicated periods of time, cell lysates were obtained and proteins were
separated by SDS-PAGE. Immunoblotting was performed with the indicated
antibodies. (B) mRNA was isolated from 3T3-L1 at the indicated times post-
induction of adipogenesis and analyzed as described in Materials and
Methods. Similar results were obtained in three different experiments.
Fig. 2. FKBP51 rapidly shuttles from mitochondria to the
nucleus at the onset of adipogenesis. (A–P) 3T3-L1 cells
were grown on coverslips and induced to differentiate for 1
(E–L) or 8 days (M–P), subjected to IIF with the indicated
antibodies, and images were analyzed by confocal microscopy.
In O and P lipid vesicles in 3T3-L1 adipocytes were stained
with LipidTOX. Nuclei were counterstained with DAPI.
Results are representative of five independent experiments.
Panel p shows a magnification of the boxed area in P. Arrows
indicate nucleoli and arrowheads indicate chromocenters.
Scale bar: 5 mm. (Q) Total (T), cytosolic (C) and nuclear
(N) fractions from 3T3-L1 cells prior (day 0) and 1 or 4 days
post-induction of differentiation were resolved by SDS-PAGE,
and analyzed by immunoblotting with the indicated antibodies.
Bands representing FKBP51 with different electrophoretic
migration (bands a–c) are indicated. (R) Total (T), cytosolic
(C) and mitochondrial (M) fractions from 3T3-L1 cells prior
(day 0) and 1 day post-induction of differentiation were
resolved by SDS-PAGE, and analyzed by immunoblotting
with the antibodies indicated in Q, and anti-Tom20 as marker
for mitochondria. (S) The nuclear fraction from 3T3-L1 cells
induced to differentiate for 1 day was incubated in the absence
(N) or the presence of alkaline phosphatase (N+AP) as
described in the Materials and Methods. The indicated samples
and total 3T3-L1 cell lysates (T) were then subjected to
western blot analysis. Blots are representative of at least three
independent experiments.
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differentiation until cells acquired their final phenotype (easily
recognized by the presence of lipid vesicles stained red by
LipidTOX; Fig. 2O,P), FKBP51 was detected in mitochondria, as
shown by colocalization with MitoTracker (supplementary
material Fig. S1I), and in the nucleus (Fig. 2M,P,p). In contrast,
Hsp70 was excluded from the nucleus of the 3T3-L1 adipocytes
(Fig. 2N). To confirm this change in FKBP51 subcellular
distribution, cytosolic and nuclear fractions from 3T3-L1 cells
before and 1 and 4 days after initiating the adipogenic program
were analyzed by western blotting (WB). In preadipocytes, as
expected, FKBP51 was mainly detected in the cytosolic fraction
(Fig. 2Q, day 0, C versus N). Importantly, 24 hours after induction
of adipogenesis, FKBP51 increased in the nuclear fraction and
decreased in the cytosol (Fig. 2Q, day 1, N versus C). After 4 days,
FKBP51 was again mainly detected in the cytosolic fraction
(Fig. 2Q, day 4, C versus N), which is similar to what was
observed in preadipocytes. To further demonstrate that the
mitochondrial fraction of FKBP51 is the one that rapidly
translocates to the nucleus, the cytoplasmic samples were
separated in mitochondrial and cytosolic fractions, proteins were
separated by SDS-PAGE and analyzed by WB. As shown in
Fig. 2R, in preadipocytes FKBP51 was detected in both fractions
(day 0, lanes C and M). In contrast, as expected based on the IFI
results, when cells were induced to differentiate the IMM was no
longer detected in the mitochondrial fraction (Fig. 2R, day 1
versus day 0, lane M), but still detected in the cytosolic one
(Fig. 2R, day 1 versus day 0, lane C). Detection of histone H3, b-
tubulin and Tom20 were used as control of the correct isolation of
the nuclear, cytosolic and mitochondrial fractions, respectively.
We would like to highlight that after induction of adipogenesis
FKBP51 in cell lysates was resolved in three bands on WB
(Fig. 2Q, days 1 and 4, lane T) suggesting that FKBP51 may be
present in forms with different degrees of phosphorylation.
Interestingly, FKBP51 bands with slower electrophoretic
migration (bands a and b) were detected in the nuclear fractions
but not in the cytosolic ones (Fig. 2Q, lane N versus C). To
ascertain whether the slow migrating bands corresponded to
phosphorylated forms of FKBP51, the nuclear extract from day 1 of
adipogenesis was incubated with alkaline phosphatase (AP) for
1 hour before the sample was applied to the gel. Alkaline
phosphatase treatment resulted in FKBP51 migrating as the faster
mobility form (Fig. 2S, N+AP versus N, band c), consistent with
band c representing dephosphorylated FKBP51. These results
demonstrate that FKBP51 is present in different cellular
compartments in forms with different degrees of phosphorylation,
with nuclear FKBP51 corresponding to highly phosphorylated
forms. Taken together these results show for the first time dynamic
changes in the subcellular distribution of FKBP51 throughout the
process of adipogenesis, raising the possibility that FKBP51
mitochondrial–nuclear shuttling is regulated by post-translational
modifications of the IMM when adipogenesis is triggered.
FKBP51 interacts in the nucleus with chromatin and the
nuclear matrix
Because we found that FKBP51 and, to a lesser extent, Hsp70
localize in the nucleus when the adipogenic program is triggered, we
investigated whether they have the capacity to interact
with chromatin and/or the nuclear matrix, a fibrogranular
ribonucleoprotein network with which chromatin and many
nuclear factors interact, thereby contributing to the spatial
organization of the genome (Nickerson, 2001). 3T3-L1 cells were
induced to differentiate for 24 hours, and then subjected to in situ
extraction. This treatment extracts proteins from the nucleoplasm
together with proteins weakly bound to chromatin and/or the nuclear
matrix (Fey et al., 1986). When 3T3-L1 cells were subjected to in
situ extraction, FKBP51 and Hsp70 were retained in the nucleus in
all cells (Fig. 3E versus A, and F versus B, respectively). This
implies that FKBP51 and Hsp70 are normally tightly associated
with chromatin and/or the nuclear matrix. To analyze whether such
interaction depends on ribonucleoproteins and/or RNA, in situ
extraction was followed by RNase A treatment. We found that
FKBP51 and Hsp70 were extracted at high levels from the nucleus
(Fig. 3I,J), indicating that their nuclear localization is stabilized by
RNA and/or ribonucleoprotein(s). As a control, C/EBPb
pericentromeric localization was not altered after RNase A
treatment (data not shown), as previously reported (Susperreguy
et al., 2011). Next, to analyze whether FKBP51 and/or Hsp70
interact not only with chromatin but also with the nuclear matrix,
chromatin was completely removed by treatment of cells with
DNase I after Triton X-100 treatment, as demonstrated by the lack
of DAPI staining (Fig. 3O). The nuclear matrix, however, was not
affected by DNase I digestion, shown by the presence of distinct
NuMA foci (Fig. 3N) (Nickerson, 2001). Interestingly, some
FKBP51 (Fig. 3M) was detected in the nucleus, partially
colocalizing with NuMA (Fig. 3P), indicating that FKBP51 can
interact with the nuclear matrix. Hsp70 was also detected
colocalizing with NuMA (data not shown). Thus, FKBP51 and
Hsp70 are retained in the nucleus upon their interaction with
chromatin and the nuclear matrix in an RNA- and/or
ribonucleoprotein-dependent manner.
FKBP51 mitochondrial–nuclear shuttling is regulated by
cAMP signaling
FKBP51 rapidly re-localizes in the nucleus when 3T3-L1
preadipocytes are induced to differentiate with MDI.
Fig. 3. FKBP51 interacts with chromatin and the nuclear matrix. 3T3-L1
cells grown on coverslips were induced to differentiate with MDI for 24 hours
and then fixed (A–D) or subjected to in situ extraction (E–H), in situ
extraction followed by RNase (I–L) or DNase treatment (M–P). Cells were
then fixed, subjected to IIF with the indicated antibodies and samples
analyzed by confocal microscopy. Results are representative of four
independent experiments, with an average of 50 cells imaged per experiment.
Scale bar: 5 mm.
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Accordingly, we determined which of the component(s) of MDI
was responsible for FKBP51 mitochondrial–nuclear shuttling.
When 3T3-L1 preadipocytes were incubated in the presence of
IBMX, FKBP51 rapidly translocated from the mitochondria to
the nucleus (Fig. 4C,D versus A,B) within 15 minutes after
IBMX had been added to the medium. DEXA treatment also
induced the translocation of the IMM to the nucleus (Fig. 4E,F),
but to a lesser extent than when the response is compared with
that to IBMX (Fig. 4E versus C). This differential response of
FKBP51 to IBMX and DEXA was also observed after 24 hours
of treatment (Fig. 4G,H versus I,J, respectively). Furthermore,
when 3T3-L1 cells incubated in the presence of IBMX for
24 hours were grown in the absence of IBMX for another
24 hours, FKBP51 shuttled back to mitochondria (Fig. 4K,L
versus G,H), supporting the notion that FKBP51 subcellular
redistribution is a dynamic event dependent on cAMP. Treatment
of 3T3-L1 cells with different concentrations of forskolin or the
cell-permeable cAMP analog dibutyryl-cAMP also induced a
rapid relocalization of FKBP51 from mitochondria to the nucleus
(data not shown). In contrast, insulin, the third component of the
adipogenic cocktail, did not promote changes in FKBP51
subcellular localization at any time point tested (data not
shown). Taken together these results demonstrate that the
dynamic mitochondrial–nuclear shuttling of FKBP51 is mainly
regulated by the second messenger cAMP signaling and to a
lesser extent by DEXA.
FKBP51 mitochondrial–nuclear shuttling is regulated by
the PKA signaling pathway
Next, we tested whether the IMM shuttling depends on activation
of PKA, a signaling pathway involved in regulation of diverse
cellular functions, among them adipocyte differentiation (Rosen
and MacDougald, 2006; Taylor et al., 1990). To investigate
whether cAMP-dependent FKBP51 redistribution is independent
of the cell type, HEK293T cells were treated in the absence or the
presence of IBMX, and FKBP51 localization assessed by IIF and
confocal microscopy. FKBP51 and PKA-ca were detected in the
mitochondria (Fig. 5A and B, respectively), as previously shown
(Gallo et al., 2011). When cells were incubated in the presence of
IBMX for 24 hours, not only FKBP51 (Fig. 5E,e versus A), but
also PKA-ca translocated to the nucleus (Fig. 5F,f versus B),
demonstrating that FKBP51 mitochondrial–nuclear redistribution
is independent of the cell type. FKBP51 and PKA-ca colocalized
mainly in the nuclear periphery (Fig. 5H,h). Importantly,
neither FKBP51 nor PKA-ca translocated to the nucleus when
HEK293T cells were treated with IBMX in the presence of
myristoylated protein kinase inhibitor (PKI), a specific PKA
inhibitor (Fig. 5I,J), suggesting that cAMP-dependent activation
of PKA regulates FKBP51 mitochondrial–nuclear translocation.
The same effect was observed when 3T3-L1 preadipocytes were
Fig. 4. FKBP51 mitochondrial–nuclear shuttling is regulated by cAMP-
dependent and steroid hormone signaling. 3T3-L1 cells were grown on
coverslips and incubated in the absence (A,B) or the presence of 520 mM
IBMX (C,D,G,H) or 1 mM DEXA (E,F,I,J) for the indicated periods of time,
and then subjected to IIF with anti-FKBP51. Nuclei were counterstained with
DAPI. (K,L) After IBMX treatment cells were grown in the absence of IBMX
for another 24 hours prior to IIF. Results are representative of four
independent experiments. Scale bar: 5 mm.
Fig. 5. Knockdown of PKA-ca prevents phosphorylation and nuclear
translocation of FKBP51. (A–P) HEK293T cells were transfected with a
scrambled siRNA (A–L) or a specific siRNA for PKA-ca (M–P). Two days
later cells were subjected to the indicated treatments, and subcellular
distribution of FKBP51 and PKA-ca were evaluated by IIF and confocal
microscopy. Scale bar: 5 mm. (Q) HEK293T cells transfected with scrambled
or specific siRNA for PKA-ca were treated with 520 mM IBMX in the
absence or presence of 0.5 mM PKI for 24 hours, and cell lysates were
analyzed by immunoblotting with the indicated antibodies. AP: cell lysates
from HEK293T cells incubated 24 hours with IBMX were treated with
alkaline phosphatase before applying them to the gel. Bands a and b
correspond to FKBP51 with different electrophoretic migration. Results are
representative of at least three independent experiments.
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treated with IBMX in the presence of myristoylated PKI
(supplementary material Fig. S2). Furthermore, inhibition of
MEK–ERK1/2 by UO126 (a MEK inhibitor) did not affect
FKBP51 nuclear translocation induced by IBMX or forskolin
(data not shown). Then, the expression of PKA-ca was reduced
using specific shRNA. PKA-c was knocked down by 50–70%, as
shown by indirect immunofluorescence (Fig. 5N) and WB
(Fig. 5Q, lanes 4 and 5). Importantly, the translocation of
FKBP51 from mitochondria to the nucleus was prevented when
PKA-ca was knocked down (Fig. 5M). Thus these results suggest
that FKBP51 is very sensitive to even a moderate decrease in the
level of expression of PKA-c. Because PKA inhibition by PKI
and PKA-ca knockdown blocked FKBP51 translocation to the
nucleus, we hypothesized that phosphorylation of FKBP51 by
PKA may regulate the subcellular distribution of the IMM. To
test this possibility, lysates from HEK293T cells incubated for
24 hours with IBMX in the absence or the presence of PKI were
analyzed by SDS-PAGE and WB. In cell lysates from HEK293T
cells treated with IBMX, FKBP51 was resolved in two bands
(Fig. 5Q, lane 1, bands a and b). In contrast, when cells were
treated with IBMX in the presence of PKI, the upper band a was
markedly reduced (Fig. 5Q, lane 2 versus 1). To ascertain whether
the slower migrating band a represents phosphorylated form of
FKBP51, lysates from IBMX-treated cells were incubated with AP
for 1 hour before they were applied to the gel. Alkaline
phosphatase caused FKBP51 to migrate mainly as the faster
mobility form (Fig. 5Q, lane 3, band b) in a similar manner to what
is observed when cells are treated with IBMX and PKI (lane 2),
and as shown in Fig. 2S for FKBP51 present in nuclear extracts of
preadipocytes induced to differentiate. Furthermore, when PKA-
ca was knocked down in HEK293T cells, FKBP51 migrated as the
faster mobility form (band b) in any condition (Fig. 5Q, lanes 4–6),
demonstrating that the slower migrating form (band a) corresponds
to the PKA-dependent phosphorylated forms of FKBP51.
FKBP51 and PKA-ca transiently localize in the nuclear
lamina and interact with lamin B
Mitochondrial–nuclear translocation of FKBP51 that takes place
during the first 2 days of the process of adipogenesis (Fig. 6F,J
versus B) was accompanied by the translocation of PKA-ca to the
nucleus (Fig. 6E,I versus A), where a marked colocalization of
PKA-ca and FKBP51 was observed (Fig. 6G,H,K,L). FKBP51
and PKA-ca were excluded from the nucleoli and by day 2, in
8064% of the cells these two proteins concentrated in the
periphery of the nucleus. FKBP51 colocalized in patches with
lamin B, one of the constituents of the nuclear lamina
(Fig. 6O,P), demonstrating that FKBP51 and PKA-ca are
present in the nuclear lamina during the early stages of
adipogenesis. Careful analysis of lamin B shows that it is
fragmented (Fig. 6M, arrowheads), a result that is in agreement
with the recently reported reorganization of the nuclear lamina
that takes place at the early stages of adipogenesis (Verstraeten
et al., 2011). Interestingly, FKBP51 and PKA-ca showed a
similar pattern of fragmentation as lamin B (Fig. 6N,J,I
arrowheads, respectively). Importantly, when the FKBP51 was
immunoprecipitated, PKA-c and lamin B co-immunoprecipitated
with the IMM from nuclei of 3T3-L1 cells differentiated for 2
days but not from nuclei of preadipocytes (Fig. 6U),
demonstrating that they not only colocalize but interact at the
onset of differentiation. When the 3T3-L1 preadipocytes were
fully differentiated, PKA-ca was detected in the nucleus and
cytoplasm (Fig. 6Q), enriched in vesicles full of lipids stained by
LipidTOX (Fig. 6S,T). These results demonstrate for the first
time that not only FKBP51 but also PKA-ca shows dynamic
changes in its subcellular distribution as adipogenesis proceeds,
possibly playing a role in nuclear lamina reorganization that takes
place at the early stages of adipogenesis.
PKA-dependent FKBP51 nuclear translocation restrains
GR transcriptional capacity
PKA-c was found associated with GR in a ligand-dependent
manner, an interaction that potentiates GR-dependent
transcription (Doucas et al., 2000). Thus, we hypothesize that
Fig. 6. FKBP51 and PKA-ca transiently colocalize in the nuclear lamina at
the onset of adipocyte differentiation. (A–T) 3T3-L1 preadipocytes grown on
coverslips were induced to differentiate for the indicated periods of time and
subcellular localization of PKA-ca and FKBP51 was assessed by IIF and confocal
microscopy. Nuclei were counterstained with DAPI. For M, O and P, IIF was
performed using anti-lamin B to label the nuclear lamina. Arrowheads in M and N
indicate loss of lamin B or FKBP51 in the nuclear rim, respectively. (Q–T) PKA-ca
is shown in light blue (Q) to distinguish it from the nucleus stained with DAPI
(blue) and the lipid vesicles were stained with LipidTOX (red; S). Scale bars: 2 mm
(A–P); 5 mm (Q–T). (U) FKBP51 was immunoprecipitated from 3T3-L1 cells
prior to (day 0) and 2 days after induction of differentiation, and
immunoprecipitated complexes were resolved by SDS-PAGE and analyzed by
immunoblotting with the indicated antibodies. NI, non-immune antibody; I,
immune antibody. Results are representative of four independent experiments.
Journal of Cell Science 126 (23)5362
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
PKA may play a dual role in the regulation of GR, i.e. on the one
hand, positively modulating GR transcriptional capacity (Doucas
et al., 2000) and, on the other hand, restraining it by increasing
the nuclear availability of FKBP51, a known GR negative
regulator (Wochnik et al., 2005). Therefore, we analyzed by
confocal microscopy the subcellular distribution of FKBP51 and
GR in preadipocytes before and 24 hours after induction of
adipogenesis. FKBP51 and GR were present in negligible
amounts in the nucleus of preadipocytes (Fig. 7A). When 3T3-
L1 cells were induced to differentiate, both FKBP51 and GR
were mainly detected in the nucleus, exhibiting a high level of
colocalization (Fig. 7B) during the first 2 days of the
differentiation process. By day 4, the subcellular localization of
FKBP51 and GR resembled the distribution observed in
preadipocytes (data not shown). When the adipocyte phenotype
was achieved, GR was mainly cytoplasmic, concentrating close
to the nucleus where it is distributed in discrete speckles
(Fig. 7D). In 3T3-L1 adipocytes, GR showed only a minor
colocalization with FKBP51 (Fig. 7E). When GR–FKBP51
interaction was evaluated, FKBP51 was not detected with GR
in preadipocytes (Fig. 7G, day 0). In contrast, when adipogenesis
was triggered, FKBP51 co-immunoprecipitated with GR, and
more FKBP51 was recovered bound to GR during the second day
of differentiation (Fig. 7G, day 1 and 2 versus day 0). Taken
together, these results demonstrate that during the early stages of
adipogenesis, GR and FKBP51 translocate to the nucleus where
they interact, and consequently, FKBP51 restrains GR
transcriptional capacity. To test this possibility, reporter gene
assays were performed. When GR transcriptional activity was
evaluated in the presence of increasing amounts of FKBP51, a
decrease in GR transcriptional capacity was detected (Fig. 7H).
Interestingly, when GR transcriptional activity was tested in the
presence of increasing concentrations of IBMX, forskolin or
dibutyryl-cAMP, a decrease in the transcriptional capacity of GR
was also measured (Fig. 7H). In contrast, when cells were
incubated with 8-(4-chlorophenylthio)-29O-methyladenosine
39,59cyclic monophosphate (Me-cAMP), an agonist that
activates the non-classic cAMP pathway (Enserink et al.,
2002), GR transcriptional activity was not affected (Fig. 7H,
Me). These results suggest that the FKBP51 nuclear translocation
induced by IBMX, forskolin and dibutyryl-cAMP, but not Me-
cAMP, was responsible, at least in part, for a decrease in GR
transcriptional capacity. To test this possibility, GR and FKBP51
subcellular distribution was analyzed by IIF in cells grown in
medium supplemented with steroid free-serum and treated with
DEXA in the absence or presence of IBMX or Me-cAMP. Upon
DEXA treatment, GR translocated to the nucleus (Fig. 7N versus
J) along with a small fraction of FKBP51 (Fig. 7M versus I) that
partially colocalized with GR (Fig. 7O,P versus K,L). In contrast,
when cells were incubated in the presence of DEXA and IBMX,
both GR and FKBP51 translocated to the nucleus (Fig. 7R,Q) and
exhibited a marked colocalization (Fig. 7S,T), possibly due to
GR–FKBP51 complexes with low transcriptional activity.
Furthermore, when cells were incubated in the presence of
DEXA and Me-cAMP, FKBP51 and GR are detected in the
nuclear compartment similarly as was observed with DEXA
Fig. 7. PKA-dependent FKBP51 nuclear translocation
restrains GR transcriptional capacity. (A–F) 3T3-L1
preadipocytes grown on coverslips were not induced (A;
day 0) or induced to differentiate (B: day 1, C–F: day 8),
and then subjected to IIF using anti-FKBP51 and anti-GR.
Nuclei were counterstained with DAPI. A, B, E and F are
merged confocal images of FKBP51 and GR. Scale bar:
10 mm. (G) GR was immunoprecipitated from 3T3-L1
preadipocytes prior and at the indicated time post-induction
of adipogenesis. Immunoprecipitated complexes were
resolved by SDS-PAGE and analyzed by immunoblotting
using the indicated antibodies. (H) HEK293T cells were
transiently transfected with MMTV-Luc and RSV-b-
galactosidase plasmids in the absence or the presence of
0.01, 0.1 or 1 mg of pCI-Neo-hFKBP51 and the amount of
transfected DNA was normalized to that of the empty
vector. After transfection cells were cultured for 24 hours
in steroid-free medium, and then incubated for 18 hours
with 1 mM DEXA in the absence or the presence of 50 and
520 mM IBMX, 15 and 30 mM forskolin (FK), 50 and
500 mM dibutyryl-cAMP (DB) or 5 and 100 mM Me-cAMP
(Me). Luciferase activity was measured and normalized to
b-galactosidase activity. Each bar represents the mean 6
s.e.m. (P,0.01) for five independent experiments.
(I–X) 3T3-L1 cells grown on coverslips were treated with
vehicle (I–L) or 1 mM DEXA in the absence (M–P) or
presence of 520 mM IBMX (Q–T) or 100 mM Me-cAMP
(U–X) for 1 hour, and then subjected to IIF with the
indicated antibodies. Nuclei were counterstained with
DAPI. Results are representative of three independent
experiments. Scale bar: 10 mm.
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alone (Fig. 7U,V versus M,N). This result is in agreement with
the lack of capacity of Me-cAMP treatment to decrease GR
transcriptional activity shown in reporter gene assays (Fig. 7H).
Taken together, these results show that cAMP–PKA signaling
regulates the glucocorticoid response by inducing the nuclear
translocation of FKBP51 that restrains its transcriptional capacity
when adipogenesis is triggered.
FKBP51 is a negative regulator of adipogenesis
To ascertain the functional importance of FKBP51 in the
process of adipogenesis, the IMM was knocked down in 3T3-
L1 preadipocytes using specific shRNA, and after puromycin
selection cells were induced to differentiate for 8 days. 3T3-
L1 preadipocytes with knocked down FKBP51 were properly
differentiated, however, adipocytes exhibited an increased
number of lipid vesicles stained by LipidTOX (Fig. 8B versus
A). Knockdown of FKBP51 accelerated the process of
adipogenesis shown by the earlier increase at day 2, and
overall higher levels in adiponectin (fourfold) and resistin
(twofold) mRNAs compared to cells treated with mock
shRNA (Fig. 8C). In contrast, ectopic expression of
FKBP51 blocked adipogenesis evidenced by the absence of
cells with lipid vesicles stained by Oil Red O (Fig. 8E versus
D). Overexpression of FKBP51 also caused a dramatic
decrease of adiponectin and resistin mRNAs (Fig. 8F),
results that are in agreement with the significant reduction
in the percentage of cells that had the capacity to differentiate
(Fig. 8G). Taken together these results show for the first time
that FKBP51 is a negative regulator in the process of
adipocyte differentiation.
Fig. 8. FKBP51 restrains differentiation
of 3T3-L1 preadipocytes. Plasmids with
mock shRNA or shRNA specific for
FKBP51 were transfected in 3T3-L1 cells,
and 48 hours later cells were induced to
differentiate. Adipogenesis was evaluated by
IIF using LipidTOX to stain vesicles
containing lipids (A,B), and by evaluating
mRNA for FKBP51, adiponectin and resistin
(C). 3T3-L1 cells were transfected with
empty vector or FLAG-FKBP51, and
24 hours later cells were induced to
differentiate and adipocyte differentiation
was evaluated by Oil Red O staining (D,E),
and by detecting mRNA for FKBP51,
adiponectin and resistin (F). b-Actin was
used as a control of loading in C and F.
(G) Fold change in the percentage of cells
that differentiated into adipocytes for control
cells, and 3T3-L1 cells in which FKBP51
was knocked down (shRNA FKBP51) or
overexpressed (Flag-FKBP51), *P,0.01.
(H) Model of FKBP51 activity in adipocyte
differentiation. In the adipogenic cocktail
MDI, IBMX and DEXA are responsible for
FKBP51 nuclear translocation. IBMX
inhibits the phosphodiesterase (PDE)
increasing intracellular cAMP that activates
PKA, and induces PKA-ca and
mitochondrial FKBP51 nuclear
translocation, where they mainly colocalize
in the nuclear lamina (NL). In the nucleus,
FKBP51 is retained by its interaction with
the nuclear matrix (NM) and chromatin,
regulating GR-target genes, and possibly
other targets.
Journal of Cell Science 126 (23)5364
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Discussion
We show that FKBP51 dynamically shuttles from mitochondria
to the nucleus at the onset of the adipogenic program (Fig. 2). To
our knowledge this is the first study that reports a dynamic
mitochondrial–nuclear shuttling event during cell differentiation.
When 3T3-L1 cells are fully differentiated, FKBP51 is detected
both in mitochondria and in the nucleus, but Hsp70 is excluded
from the latter. Thus, it is likely that the mechanism controlling
the subcellular distribution of FKBP51 and Hsp70, as well as
their roles in the nucleus during the process of adipogenesis may
diverge at different stages of cell differentiation. Interestingly,
FKBP51 rapidly translocates from mitochondria to the nucleus to
protect the cells from oxidative stress (Gallo et al., 2011),
concentrating in the nucleoli (M.D.G. unpublished results). In
contrast, when 3T3-L1 preadipocytes are induced to differentiate
FKBP51 is excluded from nucleoli (Fig. 2) and transiently
concentrates in the nuclear lamina (Fig. 6). This differential
nuclear compartmentalization of FKBP51 during cell
differentiation compared with the stress response is an indicator
of its differential role in each biological situation, indicating that
the IMM can exert different functions in the nucleus in response
to different biological cues.
Adipogenesis is controlled by many signaling pathways that
modulate the sequential activation of transcription factors
required for cells to differentiate (Rosen and MacDougald,
2006). Several reports have shown that the second messenger
cAMP is associated with immediate events of adipogenesis
through the classic PKA signaling pathway, as well as through
the non-classic pathway, the ‘exchange proteins activated by
cAMP’ (EPAC) that functions as guanine nucleotide exchange
factor for the Ras-like small GTPases Rap1 and Rap2 (Martini
et al., 2009; Petersen et al., 2008; Reusch et al., 2000; Xiao et al.,
2011). It has been proposed that the role of PKA is to decrease
cell tension by converting RhoA to an inactive GTP-free form,
which leads to relaxation of microfilaments, in part by inhibition
of Rho kinase. However, cAMP–EPAC signaling compensates
for the PKA-dependent inhibition of Rho activity for efficient
insulin–IGF signaling (Petersen et al., 2008). In the case of
FKBP51, we found that its nuclear translocation depends on PKA
(Figs 4 and 5) but not on EPAC pathway (Fig. 7), providing new
evidence of the differential biological roles of PKA and EPAC/
Rap during adipogenesis. We also found that in 3T3-L1
preadipocytes DEXA induces FKBP51 nuclear translocation but
to a lesser extent than IBMX (Figs 4 and 7). It has been reported
that glucocorticoids, through phospholipase A2, are able to
increase cAMP, when required for the differentiation of Ob1771
preadipocytes (Gaillard et al., 1991; Vassaux et al., 1992). DEXA
treatment of other cells types, e.g. 3B4.15 T cells, also results in
increased levels of intracellular cAMP due to activation of
adenylate cyclase and a decrease in phosphodiesterase activity
(Aksoy et al., 2002; Baus et al., 2001). Therefore, it is possible
that a smaller increase in intracellular cAMP level upon DEXA
treatment compared with IBMX treatment might explain the
differential degree of FKBP51 nuclear translocation observed in
each condition.
A-kinase anchoring proteins (AKAPs) target PKA to distinct
subcellular compartments providing spatial and temporal
specificity for mediation of the biological effects elicited by
this kinase. A pool of PKA is targeted by AKAPs to the
mitochondrial membrane (Taske´n and Aandahl, 2004), thus PKA
is well located to phosphorylate mitochondrial FKBP51 and
induce its translocation to the nucleus. We found, by
immunoprecipitation assays, that FKBP51 interacts with PKA-
ca (Fig. 6U). Importantly, inhibition of PKA by PKI or
knockdown of PKA-ca not only blocked the nuclear
translocation of FKBP51 but also induced dramatic changes in
the electrophoretic pattern of migration of FKBP51 (Fig. 5),
supporting the notion that FKBP51 is a PKA substrate. Using
NetPhosk 1.0, we found that Ser312 located in the TPR domain
of FKBP51 is a candidate PKA phosphoacceptor site. The TPR
domain confers to the IMM the ability to bind Hsp90 through the
EEVD motif present in the extreme C-terminus of the chaperone.
FKBP51 localization to mitochondria also depends on
TPR integrity, because FKBP51 TPR-deficient mutants are
constitutively nuclear (Gallo et al., 2011). Therefore, changes
in phosphorylation of Ser312 in the TPR domain of FKBP51
might have functional consequences in its interaction with Hsp90
and consequently in its subcellular localization. Intriguingly,
FKBP52, an IMM that shares 60% identity and 70% similarity
with FKBP51, has an alanine in this site, further suggesting that
PKA-dependent phosphorylation of Ser312 in FKBP51 could be
crucial for the different biological functions of these two highly
homologous IMMs, a possibility that is currently under
investigation.
The integrity of the TPR domain of FKBP51 is required for its
localization in mitochondria, and when its functional interaction
with Hsp90 is disrupted by drugs such as radicicol or as a result
of mutations in the TPR, FKBP51 exits the mitochondria and
concentrates in the nucleus (Gallo et al., 2011). These
observations suggest that FKBP51 localizes to mitochondria, in
part, as a mechanism to control its nuclear bioavailability. In
order to uncover the role of FKBP51 in the nucleus at the onset of
adipogenesis, it is necessary to understand how the IMM is
retained in the nucleus. By using in situ extraction assays, we
found that FKBP51 interacts with chromatin and the nuclear
matrix stabilized by ribonucleoproteins and/or RNA (Fig. 3).
Lamin B is a component of the nuclear lamina and the nuclear
matrix, FKBP51 interacts with lamin B, which may possibly be a
scaffold between the IMM and the nucleoskeleton. Different
nuclear factors have been shown to be associated to the nuclear
matrix, e.g. non-histone chromatin-associated proteins such as
HP1a, C/EBPb, a transcription factor required for adipocyte
differentiation, steroid hormone receptors and histone
deacetylases among many other factors (Susperreguy et al.,
2011; Nickerson, 2001). It has been proposed that active RNA
polymerase is located on the nuclear matrix (Cook, 1999) near
actively transcribing genes together with bound transcription
factors, facilitating their accessibility for binding to the promoter
and regulating the expression of their target genes (Sutherland
and Bickmore, 2009). FKBP51 is a negative regulator of GR and
MR transcriptional capacity (Wochnik et al., 2005; Gallo et al.,
2007), thus it is tempting to speculate that in the nuclear matrix
compartment the IMM may interact with co-repressors, co-
activators, components of the chromatin remodeling machinery
and/or transcription factors other than the members of the nuclear
receptor family, and in this way exert its control on gene
expression.
There is growing recognition that the regulatory machinery is
compartmentalized in subnuclear domains in which the
components for combinatorial control are organized and
assembled. Thus, gaining insight into the subnuclear
distribution of factors that control transcription is key to
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understand how the architecture of the nucleus is delineated to
sustain the pattern of gene expression required for the acquisition
and maintenance of the final phenotype. In this regard, we have
recently reported that the homo- and heterodimers formed by the
different forms of C/EBPb, localize to different subnuclear
domains (Susperreguy et al., 2011) where they interact with
HP1a. When proper nuclear localization of C/EBPb is altered,
adipogenesis is blocked (Susperreguy et al., 2011; Gaya et al.,
2013). Here we show that at the onset of the adipogenesis,
FKBP51 and PKA-ca are distributed through the nucleus and
also concentrate in the nuclear lamina, where they colocalize and
interact with lamin B (Fig. 6). Lamins have a scaffolding
function for several nuclear processes such as transcription,
chromatin organization, DNA replication, and to maintain
nuclear and cellular integrity (Verstraeten et al., 2007). Lamin
B was found to be fragmented during the second day of 3T3-L1
differentiation, a pattern that has been previously reported as part
of the nuclear lamina reorganization that takes place during the
process of adipogenesis (Verstraeten et al., 2011). We found that
FKBP51 and PKA-ca parallels lamin B in the fragmentation of
the nuclear lamina. Several phosphorylation sites, including those
for the cyclin B1(CCNB1)–CDC2 complex, PKC and PKA are
important in the nuclear lamina disassembly (D’Angelo and
Hetzer, 2006; Stuurman, 1997). Therefore, it is possible that
enrichment of PKA-ca in the nuclear lamina may facilitate its
reorganization by phosphorylation of lamins during adipocyte
differentiation. Notably, when cells are treated with DEXA and
IBMX, GR is present in the nucleus colocalizing with FKBP51
(Fig. 7), raising the possibility that, dependent on cAMP-
signaling, GR nuclear bioavailability may be regulated by
FKBP51 possibly by its retention in the nuclear lamina (Fig. 6
and 7) as previously shown for other transcription factors, i.e.
sterol regulatory element-binding and cFos (Andre´s and
Gonza´lez, 2009). Furthermore, it highlights the importance of
mapping the subcellular distribution of a protein to gain insight
into how it might exert different functions in response to different
stimuli.
During the last few years, several studies revealed a dramatic
and dynamic modulation of the chromatin landscape during the
first hours of adipocyte differentiation (Lefterova et al., 2008;
Nielsen et al., 2008; Siersbæk et al., 2011; Steger et al., 2010;
Susperreguy et al., 2011; Xiao et al., 2011). These changes
coincide with cooperative binding of early adipogenic
transcription factors, including GR, within and immediately
adjacent to the PPARg locus as well as other genes (Siersbæk
et al., 2011; Steger et al., 2010). However, this locus is not
transcriptionally activated until later in adipogenesis, as it has
been proposed that additional factors and/or signals are required
for its later activation (Siersbæk et al., 2011). It is also possible
that, in spite of the high level of chromatin relaxation
accompanied by increased binding of transcription factors at
the early stages of adipogenesis, gene expression is controlled by
factors that restrain the transcriptional capacity of complexes
already bound to those sites. It was also reported that
pretreatment of 3T3-L1 cells with IBMX rendered
preadipocytes partially resistant to differentiation induced by
MDI (Pantoja et al., 2008). Here we show that ectopic expression
of FKBP51 blocked the process of adipogenesis (Fig. 8). Thus an
increase in nuclear FKBP51 induced by IBMX prior induction of
differentiation may interfere with the process of adipogenesis.
Importantly, when adipogenesis is triggered, cAMP–PKA
regulates the rapid nuclear translocation of FKBP51, which
progressively increases its interaction with GR and restrains its
transcriptional capacity (Fig. 7). We propose that in this way
PKA may play a dual role in the regulation of GR, i.e. on the one
hand, positively modulating GR transcriptional capacity (Doucas
et al., 2000) and, on the other hand, restraining it by increasing
the nuclear availability of FKBP51, a known GR negative
regulator (Wochnik et al., 2005). Importantly, the presence of
FKBP51 in the nucleus may be crucial for the control not only of
GR but possibly other still unknown transcription factors, bound
to target genes that have to be repressed in spite of the high level
of chromatin remodeling that takes place within the first hours of
adipocyte differentiation. It has to be highlighted that FKBP51
not only exerts its function in the nucleus regulating transcription,
but also may also modulate biochemical events that take place in
another cellular compartment, the mitochondrion (Gallo et al.,
2011), and both the nucleus and mitochondria, are new areas for
IMM action that need to be explored.
Materials and Methods
Materials and antibodies
Rabbit polyclonal IgG against FKBP51, the BuGR2 mouse monoclonal IgG
against the GR and the JJ3 mouse monoclonal IgG against p23 were from Affinity
BioReagents (Golden, CO, USA). The mouse polyclonal IgG against GR and the
MG19 mouse monoclonal IgG against FKBP51 have been previously described
(Gallo et al., 2011). Mouse polyclonal IgG against C/EBPa, Tom20, fibrillarin and
lamin B were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA); mouse
monoclonal IgG against Hsp70, Hsp90, Cyp40 were from StressGen (Ann Arbor,
MI, USA); mouse polyclonal IgM against NuMA was from BD Transduction
Laboratories (Franklin Lakes, NJ, USA); and anti-histone H3 was from Millipore
(Billerica, MA, USA). Rabbit polyclonal IgG against PKA-ca and C/EBPb, as well
as the siRNAs for PKA-ca (cat. no. 6406) and control siRNA (cat. no. 6201)
were from Cell Signaling Technology, Inc. (Beverly, MA, USA). Secondary
antibodies labeled with Alexa Fluor 488, 546 or 647, MitoTracker and LipidTOX
were purchased from Molecular Probes (Eugene, OR, USA). HRP-conjugated
goat anti-rabbit was from Pierce (Rockford, IL, USA). Dexamethasone (DEXA),
insulin, 3-isobutyl-1-methylxanthine (IBMX), forskolin, dibutyryl-cAMP, 8-(4-
chlorophenylthio)-29O-methyladenosine 39,59cyclic monophosphate (Me-cAMP),
alkaline phosphatase (AP), mouse IgG anti-b tubulin and the HRP-conjugated
donkey anti-mouse were from Sigma Chemical Co. (St. Louis, MO, USA).
Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS)
were from Gibco (Life Technologies–Invitrogen, Carlsbad, CA, USA).
Myristoylated cAMP-dependent protein kinase inhibitor (PKI) was purchased
from Enzo Life Sciences (Exeter, UK) and UO126, a MEK inhibitor, was from
Promega (Madison, WI, USA).
Cell culture
Murine 3T3-L1 preadipocytes and human embryonic kidney HEK293T cells were
obtained from American Type Culture Collection (Manassas, VA). Cells were
grown in DMEM 4.5 g/l glucose and supplemented with 10% v/v calf serum in a
humidified 5% CO2 atmosphere at 37 C˚. Differentiation of 3T3-L1 cells was
performed as previously described (Susperreguy et al., 2011). FKBP51 was
knocked down by transfecting 3T3-L1 cells with plasmids encoding specific
shRNAs for FKBP51 (Origene, USA, cat. no. TG5000712) or scrambled shRNA
using Lipofectamine 2000. Twenty-four hours later cells were selected for 2 days
by using puromycin (4 mg/ml), and selected cells were induced to differentiate for
the times indicated in the figure legends. For FKBP51 overexpression, 3T3-L1
cells were transfected with plasmids encoding FLAG-FKBP51 or empty vector
using Lipofectamine 2000, as previously described (Susperreguy et al., 2011).
Twenty-four hours later, cells were induced to differentiate for the time indicated
in figure legends. Adipogenesis was evaluated as the percentage of cells that
accumulated lipid droplets (stained by Oil Red O or LipidTOX), and by evaluating
the expression of different adipogenic markers.
Cell fractionation
3T3-L1 cells were grown in DMEM supplemented with 10% bovine calf serum.
Cells were induced to differentiate for 1 and 4 days, and harvested by
trypsinization. Cell fractionation was performed as previously described
(Nothwang and Schindler, 2009). Briefly, cells were resuspended in CLB buffer
(10 mM HEPES, 10 mM NaCl, 1 mM KH2PO4, 5 mM NaHCO3, 5 mM EDTA,
1 mM CaCl2, 0.5 mM MgCl2 and protease inhibitors) and incubated for 5 minutes
on ice. Cells were dounced 50 times with a loose pestle, sucrose was added to
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reach a final concentration of 0.25 M, and then samples were centrifuged at
6,300 g for 5 minutes at 4 C˚. The supernatant, which corresponded to the cytosolic
fraction, was kept. The pellet (containing the nuclei) was washed once with CLB
buffer and 0.25 M sucrose, and then the nuclei were lysed using TSE buffer
[10 mM Tris-HCl, 300 mM sucrose, 1 mM EDTA, 0.1% IGEPAL-CA 630 (v/v),
pH 7.5]. Total, cytoplasmic and nuclear fractions were resolved by SDS-PAGE
and analyzed by immunoblotting, as previously described (Susperreguy et al.,
2011). Cell fractionation of cytosol and mitochondria was performed as previously
described (Gottlieb and Granville, 2002; Gallo et al., 2011).
Western blot analysis (WB)
3T3-L1 preadipocytes left untreated or induced to differentiate for the indicated
times were washed with PBS and scraped into SDS lysis buffer (60 mM Tris-HCl,
pH 6.8, 1% SDS) for whole-cell lysates, as described previously (Liao et al.,
1999). In some experiments, whole-cell lysates were incubated with 40 units of
alkaline phosphatase for 1 hour at 37 C˚ prior to immunoblotting (Liao et al.,
1999). The same amount of protein was loaded in all cases, and b-tubulin was used
as loading control.
RT-PCR analysis
Total RNA was prepared from 3T3-L1 preadipocytes left untreated or induced to
differentiate for different periods of time, using the Trizol reagent (Life
Technologies–Invitrogen, Carlsbad, CA, USA) according to manufacturer’s
instructions, as previously described (Susperreguy et al., 2011). The PCR-
amplified products were visualized after ethidium bromide staining on a 2%
agarose gel. The mRNA levels of all the genes were normalized using b-actin as an
internal control. Primer sequences are available upon request.
Indirect immunofluorescence assays and Oil Red O staining
Indirect immunofluorescence (IIF) was performed as previously described (Piwien
Pilipuk et al., 2003; Susperreguy et al., 2011). All IIF conditions were tested to
avoid non-specific reactions. The specificity of anti-FKBP51 had been tested
already (Gallo et al., 2011). Mitochondria were labeled with MitoTracker
according to the manufacturer’s instructions. Nuclei were stained with DAPI
and coverslips were mounted in Vectashield. For the staining of lipid vesicles, after
DAPI staining coverslips were inverted onto 25 ml of LipidTOX (diluted 1/300 in
PBS) and incubated for 30 minutes at room temperature prior to mounting the
coverslips in Vectashield. For Oil Red O staining, cells were washed with PBS,
fixed with 4% formaldehyde at room temperature for 1 hour, washed twice with
water, and stained with Oil Red O, as previously described (Susperreguy et al.,
2011). Laser-scanning confocal microscopy was performed with LSM5 Pascal or a
Meta microscope (Carl Zeiss. Oberkochen, Germany), using a C-Apochromat 636/
1.4 NA oil-immersion objective and images were taken in the middle section of the
cell nucleus. Percentage of cells with the pattern of protein distribution presented
in the figures was obtained by observation of 200–300 cells per condition and per
experiment, made independently by two observers.
In situ cell extraction
The extractions were performed directly on cells grown on coverslips (in situ
extraction) as previously described (Susperreguy et al., 2011), using a protocol
adapted from Fey et al. (Fey et al., 1986).
Immunoprecipitation assays
3T3-L1 cells were harvested in ice-cold Earle’s balanced saline, washed twice, and
ruptured by Dounce homogenization in 1 volume of HEM buffer at pH 7.4
(10 mM HEPES, 1 mM EDTA, 20 mM Na2MoO4). GR was immunoprecipitated
as previously described (Echeverrı´a et al., 2009). Proteins in the immune pellet
were resolved by SDS-PAGE and analyzed by WB.
Reporter gene assays
HEK293T cells were transiently transfected by the calcium phosphate co-
precipitation assay with MMTV-Luc (0.5 mg), and RSV-b-galactosidase (0.1 mg),
pCIneo-FLAG-hFKBP51 and empty vector in order to transfect the same amount
of DNA in all conditions. Twenty-four hours after transfection, cells were grown in
medium supplemented with steroid-free serum and treated or not with 1 mM
DEXA in the absence or presence of IBMX, forskolin, dibutyryl-cAMP or Me-
cAMP, as indicated in the figure legends. Luciferase and b-galactosidase activity
were measured using a VeritasTM microplate luminometer (Turner Biosystems,
USA). Luciferase values were normalized to b-galactosidase activity. Each
condition was tested in duplicate in each experiment. A two-sample t-test
(SigmaStat) was used to judge statistical significance where a value of P,0.05 was
considered statistically significant.
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Fig. S1. FKBP51 rapidly shuttles from mitochondria to the nucleus when 3T3-L1 preadipocytes are induced to differentiate. 3T3-L1 
cells grown on coverslips were induced to differentiate for the indicated period of time and subcellular localization of FKBP51, and 
Tom20 were assessed by IIF and confocal microscopy. Nuclei were counterstained with DAPI and mitochondria with MitoTracker. 
Arrows indicate nucleoli (D). Images are representative of three independent experiments. Scale bar: 3 μm
Fig. S2.   3T3-L1 cells were grown on coverslips and incubated in the absence (A-D), the presence of 520 μM IBMX (E-H, h) or IBMX 
and 0.5 μM PKI (I-L) for 24 h, and then subjected to IIF analysis using anti α-FKBP51and anti-PKAc-α. Nuclei were counterstained 
with DAPI. Results are representative of four independent experiments. Scale bar: 10 μm.
